Restricted accessResearch articleFirst published online 2012-04
Polymorphism of THBS1 rs1478604 A>G in 5-Untranslated Region Is Associated with Lymph Node Metastasis of Gastric Cancer in a Southeast Chinese Population
Thrombospondin-1 plays an important role in cancer development and progression. This study investigated if a correlation exists between single-nucleotide polymorphisms (SNPs) in the Thrombospondin-1 gene (THBS1) and gastric cancer. We conducted a case–control study on a randomly recruited population of 283 patients and 283 healthy individuals from the city of Fuzhou in Southeast China. Individuals were genotyped for four SNPs (rs1478604 A>G, rs2228261 C>T, rs2292305 T>C, and rs3743125 C>T) in THBS1 using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. THBS1 genotypic distributions between the case and control groups were tested for correlations with cancer development. Comparisons between the case and control groups showed no significant differences in the genotypic distributions of rs1478604 A>G, rs2228261 C>T, and rs3743125 C>T. However, we found a statistically significant association between homozygous CC of THBS1 rs2292305 T>C and development of highly differentiated carcinoma (HDC). The rs1478604 A>G variant was found to be associated with invasion and lymph node metastasis in gastric cancer. After logistic regression and stratification analysis, rs1478604 A>G was more strongly associated with lymph node metastasis in HDC gastric cancer. The power to detect an effect for rs1478604 A>G in HDC was 90%. These findings indicate that the THBS1 rs1478604 A>G variant is linked with differential risks for gastric cancer nodal metastasis. These results support further investigation of THBS1 as a potential therapeutic target in gastric cancer.
Get full access to this article
View all access options for this article.
References
1.
AlboD., ShinoharaT., TuszynskiG.P.2002. Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer. J Surg Res, 108:51–60.
2.
AltmanD.G.1991. Practical Statistics for Medical Research. Chapman & Hall/CRC: Boca Raton, FL.
3.
BaiW., WangL., JiW., GaoH.2009. Expression profiling of supraglottic carcinoma: PTEN and thrombospondin 2 are associated with inhibition of lymphatic metastasis. Acta Otolaryngol, 129:569–574.
4.
CaiL., ZhengZ.L., ZhangZ.F.2003. Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World J Gastroenterol, 9:214–218.
5.
CanfieldA.E., SchorA.M.1995. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J Cell Sci, 108,Pt 2:797–809.
6.
CarlsonC.S., EberleM.A., RiederM.J., YiQ., KruglyakL., NickersonD.A.2004. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet, 74:106–120.
7.
CarpizoD., Iruela-ArispeM.L.2000. Endogenous regulators of angiogenesis—emphasis on proteins with thrombospondin—type I motifs. Cancer Metastasis Rev, 19:159–165.
8.
ChatterjeeS., PalJ.K.2009. Role of 5'- and 3'-untranslated regions of mRNAs in human diseases. Biol Cell, 101:251–262.
9.
ChijiwaT., AbeY., IkomaN., YamazakiH., TsukamotoH., SuemizuH.et al.2009. Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gammaCnull (NOG) mice. Int J Oncol, 34:5–13.
10.
de BakkerP.I., McVeanG., SabetiP.C., MirettiM.M., GreenT., MarchiniJ.et al.2006. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet, 38:1166–1172.
11.
FaulF., ErdfelderE., LangA.G., BuchnerA.2007. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods, 39:175–191.
12.
ForsterS., GretschelS., JonsT., YashiroM., KemmnerW.THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling. Mod Pathol, 2011[Epub ahead of print]10.1038/modpathol.2011.99.
13.
ForstiA., LiX., WagnerK., TavelinB., EnquistK., PalmqvistR.et al.2010. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression. Genes Chromosomes Cancer, 49:270–281.
14.
GrecoS.A., ChiaJ., InglisK.J., CozziS.J., RamsnesI., ButtenshawR.L.et al.2010. Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation. BMC Cancer, 10:494.
15.
HamiltonS.R., AaltonenL.A.2000. Pathology and genetics. Tumor of the Digestic System. World Health Organization Classification of tumors, IARC: Lyon, 39.
16.
HannahB.L., MisenheimerT.M., AnnisD.S., MosherD.F.2003. A polymorphism in thrombospondin-1 associated with familial premature coronary heart disease causes a local change in conformation of the Ca2+-binding repeats. J Biol Chem, 278:8929–8934.
17.
HawighorstT., OuraH., StreitM., JanesL., NguyenL., BrownL.F.et al.2002. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene, 21:7945–7956.
18.
HsiehY.Y., ChangC.C., TsaiF.J., LinC.C., TsaiC.H.2008. T allele for VEGF-460 gene polymorphism at 5'-untranslated region is associated with higher susceptibility of leiomyoma. Biochem Genet, 46:356–361.
19.
International HapMap Consortium. 2003. The International HapMap Project. Nature, 426:789–796.
20.
JemalA., SiegelR., WardE., HaoY., XuJ., MurrayT.et al.2008. Cancer statistics, 2008. CA Cancer J Clin, 58:71–96.
21.
JustenhovenC., HamannU., PeschB., HarthV., RabsteinS., BaischC.et al.2004. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev, 13:2059–2064.
22.
KazerounianS., YeeK.O., LawlerJ.2008. Thrombospondins in cancer. Cell Mol Life Sci, 65:700–712.
23.
KimJ., KimC., KimT.S., BangS.I., YangY., ParkH.et al.2006. IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem Biophys Res Commun, 344:1284–1289.
24.
KiyonoK., SuzukiH.I., MorishitaY., KomuroA., IwataC., YashiroM.et al.2009. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma. Cancer Sci, 100:1809–1816.
25.
KochW., HoppmannP., de WahaA., SchomigA., KastratiA.2008. Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence. Hum Mol Genet, 17:1120–1126.
26.
LaurenP.1965. The Two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand, 64:31–49.
27.
LawlerJ.2002. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med, 6:1–12.
28.
LazarD., RaicaM., SporeaI., TabanS., GoldisA., CornianuM.2006. Tumor angiogenesis in gastric cancer. Rom J Morphol Embryol, 47:5–13.
29.
LiZ., ZhangZ., HeZ., TangW., LiT., ZengZ.et al.2009. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. http://analysis.bio-x.cnCell Res, 19:519–523.
30.
LuJ., WangL.E., XiongP., SturgisE.M., SpitzM.R., WeiQ.2007. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis, 28:988–994.
31.
MiyamotoN., YamamotoH., TaniguchiH., MiyamotoC., OkiM., AdachiY.et al.2007. Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability. Cancer Lett, 254:42–53.
32.
NakaoT., KuritaN., KomatsuM., YoshikawaK., IwataT., UtsunomiyaT.et al.2011. Expression of thrombospondin-1 and Ski are prognostic factors in advanced gastric cancer. Int J Clin Oncol, 16:145–152.
33.
PetoJ.2001. Cancer epidemiology in the last century and the next decade. Nature, 411:390–395.
34.
PickeringB.M., WillisA.E.2005. The implications of structured 5' untranslated regions on translation and disease. Semin Cell Dev Biol, 16:39–47.
35.
QiuL.X., MaoC., YaoL., YuK.D., ZhanP., ChenB.et al.2010. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat, 122:489–493.
36.
SargiannidouI., ZhouJ., TuszynskiG.P.2001. The role of thrombospondin-1 in tumor progression. Exp Biol Med (Maywood, NJ), 226:726–733.
37.
SfarS., SaadH., MosbahF., ChouchaneL.2009. Combined effects of the angiogenic genes polymorphisms on prostate cancer susceptibility and aggressiveness. Mol Biol Rep, 36:37–45.
38.
SfarS., SaadH., MosbahF., GabboujS., ChouchaneL.2007. TSP1 and MMP9 genetic variants in sporadic prostate cancer. Cancer Genet Cytogenet, 172:38–44.
39.
SignoriE., BagniC., PapaS., PrimeranoB., RinaldiM., AmaldiF.et al.2001. A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency. Oncogene, 20:4596–4600.
40.
SteninaO.I., ByzovaT.V., AdamsJ.C., McCarthyJ.J., TopolE.J., PlowE.F.2004. Coronary artery disease and the thrombospondin single nucleotide polymorphisms. Int J Biochem Cell Biol, 36:1013–1030.
41.
SteninaO.I., TopolE.J., PlowE.F.2007. Thrombospondins, their polymorphisms, and cardiovascular disease. Arterioscler Thromb Vasc Biol, 27:1886–1894.
42.
SteninaO.I., UstinovV., KrukovetsI., MarinicT., TopolE.J., PlowE.F.2005. Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites. Faseb J, 19:1893–1895.
43.
ValdesA.M., HassettG., HartD.J., SpectorT.D.2005. Radiographic progression of lumbar spine disc degeneration is influenced by variation at inflammatory genes: a candidate SNP association study in the Chingford cohort. Spine (Phila Pa 1976), 30:2445–2451.
44.
WongB.C., LamS.K., WongW.M., ChenJ.S., ZhengT.T., FengR.E.et al.2004. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA, 291:187–194.
45.
YangL.2006. Incidence and mortality of gastric cancer in China. World J Gastroenterol, 12:17–20.
46.
ZhangJ., ItoR., OueN., ZhuX., KitadaiY., YoshidaK.et al.2003. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma. Virchows Arch, 442:563–568.
47.
ZhouM.G., WangX.F., HuJ.P., LiG.L., ChenW.Q., ZhangS.W.et al.2010. [Geographical distribution of cancer mortality in China, 2004–2005]Zhonghua Yu Fang Yi Xue Za Zhi, 44:303–308.
48.
ZwickerJ.I., PeyvandiF., PallaR., LombardiR., CancianiM.T., CairoA.et al.2006. The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. Blood, 108:1280–1283.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
